Clinical Trials Logo

Filter by:
NCT ID: NCT05300126 Completed - Palliative Care Clinical Trials

Brief Hypnosis Intervention for Palliative Care Patients and Their Relatives.

HypnoPal
Start date: February 14, 2022
Phase: N/A
Study type: Interventional

The study objective is to assess the feasibility of hypnosis sessions for palliative care patients in home care and of their relatives. The intervention consists of four 15-minute hypnosis sessions for the patients and for one family member, taking place at the patient's home. Recordings will be given to practice self-hypnosis.

NCT ID: NCT05298917 Completed - Cornea Clinical Trials

Influence of Silicone Hydrogel Extended Contact Lens Wear on Corneal Sensitivity

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Soft contact lens wear reduces the amount of oxygen reaching the eye, which may have an influence on corneal sensitivity. The aim of this study is to measure corneal sensitivity with means of liquid jet esthesiometry at baseline and after 6 days of continuous, extended contact lens wear.

NCT ID: NCT05297435 Completed - Clinical trials for Trauma, Psychological; Somatic

Psychotraumatology in Somatic Medicine

Start date: January 19, 2021
Phase:
Study type: Observational [Patient Registry]

Psychotraumatology is clinically highly relevant, especially in the medical-somatic disciplines. Despite progress in recent decades, the clinical care is still inadequate - with unfavorable health effects for affected patients. There are avoidable burdens for involved clinicians and the health care system as a whole, also in terms of costs. With this background, our long-term project combines different research levels. Besides clarifying the clinical phenomenon, it aims to examine 1) the influence of traumatization on the physician-patient interaction as well as 2) the current psychological stress of the patients. Furthermore, 3) moderating factors on the side of the physicians, such as professional experience on the physician-patient interaction will be examined.

NCT ID: NCT05294965 Completed - Thermogenesis Clinical Trials

Beta 2 Adrenergic Stimulation vs Cold Exposure to Activate Human Brown Adipose Tissue

ASCENT
Start date: April 27, 2022
Phase: Early Phase 1
Study type: Interventional

The purpose of the study is to asses brown adipose tissue activity in humans after intravenous administration of the selective beta-2-adrenergic agonist fenoterol as compared to the natural activator of brown adipose tissue, a mild cold stimulus.

NCT ID: NCT05294627 Completed - Prostate Cancer Clinical Trials

Validation of the Stockholm3 Test for Detection of Prostate Cancer in the Swiss Population

Start date: January 1, 2020
Phase:
Study type: Observational

The purpose of this study is to collect blood samples to investigate the prognostic performance of the STHLM3 test in a population of Swiss and German men suspected of harbouring prostate cancer based on a combination of elevated PSA levels (e.g. >2.5 ng/ml) and/or pathological digital rectal examination and/or MRI-findings.

NCT ID: NCT05291637 Completed - Clinical trials for Stroke, Acute Ischemic

Posterior cerebraL ArTery Occlusion Study

PLATO
Start date: January 5, 2022
Phase:
Study type: Observational

For this retrospective study, the investigators will collect and analyze data of patients who presented with posterior artery occlusion and underwent mechanical thrombectomy (the type of endovascular stroke treatment) and intravenous thrombolysis (the type of non-endovascular stroke treatment). The electronic health records will be queried for the demographic, medical history, and outcomes data of all patients with posterior cerebral artery occlusion who underwent mechanical thrombectomy, intravenous thrombolysis (IVT), or medical management.

NCT ID: NCT05284292 Completed - Caregiver Clinical Trials

GUARDIAN: The Social Robot Companion to Support Homecare Nurses

GUARDIAN
Start date: March 16, 2022
Phase: N/A
Study type: Interventional

The primary objective of this study is to verify the acceptability of the GUARDIAN system by the elderly, detected through the scale Unified Theory of Acceptance and Use of Technology (UTAUT). The GUARDIAN platform consists of two connected apps: one dedicated to the caregiver and one dedicated to the older people, plus a robot (Misty II). Misty II will live with the elderly, it will have the task of detecting his presence inside the house, reminding him of appointments, assisting him in his daily activities and diminishing the sense of loneliness. The application dedicated to the caregiver receives the data and self reports of the elderly from the robot, in order to constantly offer an updated picture of the condition of the elderly and to keep them informed about their condition and well-being.

NCT ID: NCT05279183 Completed - Appetite Clinical Trials

Assessment of Reward Responses to Erythritol Using Flavor Preference Learning

Start date: March 17, 2022
Phase: N/A
Study type: Interventional

The aim of this project is to investigate the reward responses to oral erythritol compared to sucrose and sucralose using flavor preference learning in healthy participants. In addition, the release of GI hormones, glycemic control, appetite-related sensations, and emotional state in response to erythritol will be investigated.

NCT ID: NCT05277636 Completed - Healthy Clinical Trials

Acute Effects of R- and S-MDMA in Healthy Subjects

R-S-MDMA
Start date: October 1, 2022
Phase: Phase 1
Study type: Interventional

Racemic ±3,4-methylenedioxymethamphetamine (MDMA) is a psychoactive substance and prototypical empathogen acutely inducing feelings of heightened mood, empathy, trust and closeness to others. These acute subjective effects of MDMA may be helpful to assist psychotherapy and MDMA is currently investigated in phase 3 trials as a possible treatment in post-traumatic stress disorder.

NCT ID: NCT05274334 Completed - Clinical trials for De Novo Lipogenesis (DNL)

Measurement of Lipogenic Flux by Deuterium Resolved Mass Spectrometry Via Non-invasive Breath Analysis

D2OBREATH
Start date: May 11, 2022
Phase: N/A
Study type: Interventional

This proof of concept- study is to measure de novo lipogenesis (DNL) non-invasively in exhaled breath in overnight-fasted humans by triggering feeding response by deuterium resolved mass spectrometry.